154 related articles for article (PubMed ID: 8929984)
1. Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice.
Hassouna I; Wickert H; Zimmermann M; Gillardon F
Neurosci Lett; 1996 Feb; 204(1-2):85-8. PubMed ID: 8929984
[TBL] [Abstract][Full Text] [Related]
2. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
Aoki E; Yano R; Yokoyama H; Kato H; Araki T
Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
4. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
[TBL] [Abstract][Full Text] [Related]
6. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
Tanji H; Araki T; Nagasawa H; Itoyama Y
Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452
[TBL] [Abstract][Full Text] [Related]
7. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Nishi K
Brain Res; 1997 Oct; 771(1):133-41. PubMed ID: 9383016
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.
Lin AM; Yang CH; Ueng YF; Luh TY; Liu TY; Lay YP; Ho LT
Neurochem Int; 2004 Jan; 44(2):99-105. PubMed ID: 12971912
[TBL] [Abstract][Full Text] [Related]
10. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons.
Gouty S; Brown JM; Rosenberger J; Cox BM
Neuroscience; 2010 Aug; 169(1):269-78. PubMed ID: 20417255
[TBL] [Abstract][Full Text] [Related]
11. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Turmel H; Hartmann A; Parain K; Douhou A; Srinivasan A; Agid Y; Hirsch EC
Mov Disord; 2001 Mar; 16(2):185-9. PubMed ID: 11295768
[TBL] [Abstract][Full Text] [Related]
12. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model.
Xu BB; Liu CQ; Gao X; Zhang WQ; Wang SW; Cao YL
J Asian Nat Prod Res; 2005 Jun; 7(3):215-24. PubMed ID: 15621629
[TBL] [Abstract][Full Text] [Related]
14. Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment.
Inoue T; Tsui J; Wong N; Wong SY; Suzuki F; Kwok YN
Brain Res; 1999 May; 826(2):306-8. PubMed ID: 10224310
[TBL] [Abstract][Full Text] [Related]
15. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
16. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum.
Thomas B; Mohanakumar KP
J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
Yang W; Chen YH; Liu H; Qu HD
Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
[TBL] [Abstract][Full Text] [Related]
20. Six weeks of voluntary exercise don't protect C57BL/6 mice against neurotoxicity of MPTP and MPP(+).
Aguiar AS; Tristão FS; Amar M; Chevarin C; Glaser V; de Paula Martins R; Moreira EL; Mongeau R; Lanfumey L; Raisman-Vozari R; Latini A; Prediger RD
Neurotox Res; 2014 Feb; 25(2):147-52. PubMed ID: 23873578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]